Novo Nordisk A/S | NOVOB - Current Assets


Novo Nordisk reported DKK172.45B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Bausch Health Companies USD 6.16B 92M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
Merck USD 47.56B 10.49B Sep/2025
Novartis USD 30.46B 2.26B Dec/2025
Novo Nordisk DKK 172.45B 9.43B Dec/2025
Novo Nordisk DKK 25.71B 148.69B Jun/2025
Pacira USD 547.97M 14.78M Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
Supernus Pharmaceuticals USD 644.18M 50.29M Dec/2025